scispace - formally typeset
M

Mark Zak

Researcher at Genentech

Publications -  84
Citations -  2602

Mark Zak is an academic researcher from Genentech. The author has contributed to research in topics: Janus kinase & Nicotinamide phosphoribosyltransferase. The author has an hindex of 25, co-authored 83 publications receiving 2281 citations. Previous affiliations of Mark Zak include University of California, San Diego & Scripps Research Institute.

Papers
More filters
Journal ArticleDOI

Total Synthesis of Thiostrepton. Retrosynthetic Analysis and Construction of Key Building Blocks

TL;DR: It is shown that retrosynthetic analysis of thiostrepton reveals compounds 23, 24, 26, 28, and 29 as potential key building blocks for the projected total synthesis, and a method was developed for the direct coupling of the labile dehydropiperidine key building block 28 to the more advanced and stable peptide intermediate 27 through capture with the highly reactive alanine equivalent 67.
Journal ArticleDOI

Universal solid-phase approach for the immobilization, derivatization, and resin-to-resin transfer reactions of boronic acids.

TL;DR: This concept was illustrated by a set of optimized procedures for the Suzuki cross-coupling and the borono-Mannich reactions, which helps eliminate time-consuming cleavage and transfer operations, thereby considerably simplifying the outlook of combinatorial library synthesis by manual or automated means.
Journal ArticleDOI

A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors

TL;DR: The results indicate that the biological processes that require TYK2 catalytic function in humans are restricted to the IL-12 and IL-23 pathways, and suggest that inhibition of tyrosine kinase catalytic activity may be an efficacious approach for the treatment of select autoimmune diseases without broad immunosuppression.